Location History:
- Rockville, MD (US) (1998)
- Bethesda, MD (US) (2000 - 2022)
Company Filing History:
Years Active: 1998-2025
Title: Innovator Zhengping Zhuang: A Pioneer in Cancer Research
Introduction
Zhengping Zhuang, located in Bethesda, MD, is a distinguished inventor known for his contributions to cancer research. With a total of seven patents to his name, Zhuang's innovations focus on advancing the field of oncology and enhancing treatment methods for patients afflicted with cancer.
Latest Patents
Among Zhuang's latest patents is one titled "Oxabicycloheptanes for modulation of immune response." This invention outlines a method of treating cancer by administering an effective amount of a PP2A inhibitor to the subject. Another significant patent, "Use of isovalerylspiramycins as anti-cancer agents to inhibit metastasis," details a pharmaceutical composition that utilizes 4″-O-isovalerylspiramycin I, II, and III. This composition counters tumorigenesis and reduces or prevents metastasis by inhibiting selenoprotein H, thereby triggering genomic instability and cell-cycle arrest in cancer cells.
Career Highlights
Zhengping Zhuang's professional journey has been marked by significant contributions to medical research, particularly in the areas of cancer treatment and therapies. His work has garnered attention and recognition in the scientific community, leading to his involvement with notable organizations such as the United States of America as represented by the Department of Health and Human Services and the United States of America as represented by the Secretary of Health and Human Services.
Collaborations
Throughout his career, Zhuang has had the privilege of collaborating with esteemed colleagues, including Lance A. Liotta and Michael E. Buck. These collaborations have further enriched his research and expertise, allowing him to contribute significantly to advancements in cancer therapies.
Conclusion
Zhengping Zhuang stands out as an influential inventor whose work is paving the way for innovative cancer treatments. His patents reflect a commitment to improving patient outcomes and understanding the complexities of cancer biology. As he continues to explore new frontiers in research, Zhuang's contributions are sure to leave a lasting impact on the field of oncology.